|
|
|
|
QH RESEARCH LIMITED
REGISTERED NUMBER:10026746
|
BALANCE SHEET
AS AT 31 DECEMBER 2024
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.
The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 July 2025.
The notes on pages 2 to 4 form part of these financial statements.
|
|
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
QH Research Limited is a private company limited by shares, incorporated in England and Wales
(registered number: 10026746). Its registered office is 3 Forbury Place, 23 Forbury Road, Reading, England, RG1 3JH.
The principal activity of the Company throughout the year continued to be that of a holding company.
2.Accounting policies
|
|
|
Basis of preparation of financial statements
|
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
|
|
|
Exemption from preparing consolidated financial statements
|
The Company is a parent company that is also a subsidiary included in the consolidated financial statements of a larger group by a parent undertaking established under the law of any part of the United Kingdom and is therefore exempt from the requirement to prepare consolidated financial statements under section 400 of the Companies Act 2006.
Investments in subsidiaries are measured at cost less accumulated impairment.
|
|
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
|
|
The average monthly number of employees, including directors, during the year was 3 (2023 - 3).
|
|
|
Investments in subsidiary companies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allotted, called up and fully paid
|
|
|
|
|
|
|
|
|
|
|
|
5,000,100 (2023 - 5,000,000) A Ordinary shares shares of £0.00001 each
|
|
|
|
|
|
5,000,100 (2023 - 5,000,000) B Ordinary shares shares of £0.00001 each
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related party transactions
|
|
|
As a wholly owned company within the IQVIA group, the company is exempt from the requirements of
FRS 102 to disclose transactions with other members of the group.
|
QH Research Limited is part of the IQVIA group, with IQVIA Holdings Inc. as its ultimate parent company.
IQVIA Holdings Inc. is registered in the United States of America, with its registered office at 4820 Emperor Blvd, Durham, NC 27703. The financial results of QH Research Limited and its wholly owned subsidiary, Quality Health Limited, are consolidated within the financial statements of IQVIA Holdings Inc.
|
|
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
The auditors' report on the financial statements for the year ended 31 December 2024 was unqualified.
The audit report was signed on 29 July 2025 by Andrew Irvine (Senior statutory auditor) on behalf of Shorts.
|